Hepatic encephalopathy HE is a reversible syndrome of impaired brain function occurring in patients with advanced liver diseases. The precise pathophysiology of HE is still under discussion; the leading hypothesis focus on the role of neurotoxins, impaired neurotransmission due to metabolic changes in liver failure, changes in brain energy metabolism, systemic inflammatory response and alterations of the blood brain barrier. HE produces a wide spectrum of nonspecific neurological and psychiatric manifestations. Minimal HE is diagnosed by abnormal psychometric tests.

Author:Doumi Zulkibar
Language:English (Spanish)
Published (Last):21 June 2006
PDF File Size:5.19 Mb
ePub File Size:6.16 Mb
Price:Free* [*Free Regsitration Required]

Alternativamente, as ROS podem ativar a tirosina para formar tirosil, um radical que, por sua vez oxida No para produzir nitrotirosina. Sener et al. GSA e MG foram acentuadamente mais potentes como convulsivantes do que a guanidina e creatinina.

Kunze K. Metabolic encephalopathies. J Neurol. Hospital-acquired renal insufficiency: a prospective study. Am J Med. Hospital-acquired renal insufficiency. Am J Kidney Dis. Acute renal failure. Uremic encephalopathies: clinical, biochemical, and experimental features.

Raskin NH. Neurological complications of renal failure. In: Aminoff MJ, editor. Neurology and general medicine. New York: Churchill Livingstone; Burn DJ, Bates D. Neurology and the kidney. J Neurol Neurosurg Psychiatry. Clinical and pathophysiological aspects of neurological complications in renal failure. Acta Neurol Belg. Metabolic encephalopathy as a complication of renal failure: mechanisms and mediators. New Horiz. Review on uremic toxins: classification, concentration, and interindividual variability.

Kidney Int. Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes. J Clin Invest. Lipid peroxidation uraemia: malondialdehyde: a putative uraemic toxin. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients. Free Radic Biol Med. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension.

Inflammation and oxidative stress in ESRD--the role of myeloperoxidase. J Nephrol. Turpaev KT. Nitric oxide in intercellular communication. Mol Biol Mosk. Hogg N, Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochim Biophys Acta. Murphy MP. Nitric oxide and cell death. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?

FEBS Lett. Nitric oxide rapidly scavenges tyrosine and tryptophan radicals. Biochem J. Nitric oxide NO modulates the neurogenic control of blood pressure in rats with chronic renal failure CRF. Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy and angiotensin-converting enzyme inhibition.

J Am Soc Nephrol. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Prostaglandins Other Lipid Mediat. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage.

Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats. Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats. Nephrol Dial Transplant. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency. Clin Chim Acta. Guanidino compound levels in brain regions of non-dialyzed uremic patients.

Neurochem Int. Guanidino compounds in uraemic dialyzed patients. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis. Guanidino compounds as uremic neuro toxins. Semin Dial. The uremic guanidine compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice.

Brain Res. Behavioral changes in the course of chronic renal insufficiency in rats. Pol J Pharmacol. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. J Neurochem. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure. Kynurenine and its metabolites in the rat with experimental renal insufficiency. J Physiol Pharmacol. Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure.

Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol. Mechanism of inhibitory effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency.

Adv Exp Med Biol. Ksiazek A, Solski J. Noradrenaline turnover in the tissues of uraemic rats. Plasma and brain catecholamines in experimental uremia: acute and chronic studies.

Life Sci. Neurotransmitter and monoaminergic amino acid precursor levels in rat brain: effects of chronic renal failure and malnutrition. Miner Electrolyte Metab. Derangements in acetylcholine metabolism in brain synaptosomes in chronic renal failure. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.

Ann Neurol. N-methyl-D-aspartate receptors contribute to guanidinosuccinate-induced convulsions in mice. Neurosci Lett. N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: behavioural and electrophysiological evidence. Uremic toxins. Kidney Int Suppl. Uremic encephalopathy. Clin Nephrol. Vanholder R.


Hepatic encephalopathy




Related Articles